BRIEF published on 05/11/2026 at 08:05, 18 days 10 hours ago Pentixapharm soumet une demande d'autorisation d'essai clinique (IND) à la FDA pour l'étude de phase 3 PANDA. Diagnostic De Précision Pentixapharm Phase 3 PANDA Soumission D'autorisation De Mise Sur Le Marché (IND) À La FDA Imagerie Cardiovasculaire
BRIEF published on 05/11/2026 at 08:05, 18 days 10 hours ago Pentixapharm Submits IND to FDA for Phase 3 PANDA Study Pentixapharm Precision Diagnostics FDA IND Submission Phase 3 PANDA Cardiovascular Imaging
PRESS RELEASE published on 05/11/2026 at 08:00, 18 days 10 hours ago Pentixapharm Announces IND Submission to FDA for Phase 3 PANDA Study of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic Pentixapharm submits IND to FDA for Phase 3 PANDA study of CXCR4-targeted cardiovascular diagnostic, aiming at precision diagnostics in primary aldosteronism Pentixapharm IND Submission Phase 3 PANDA Study CXCR4-targeted Cardiovascular Diagnostic
BRIEF published on 05/07/2026 at 08:05, 22 days 10 hours ago Point sur le développement financier et clinique de Pentixapharm au premier trimestre 2026 Résultats Financiers Développement Clinique Gestion Des Coûts Produits Radiopharmaceutiques Commentaires Réglementaires
BRIEF published on 05/07/2026 at 08:05, 22 days 10 hours ago Pentixapharm Q1 2026 Financial and Clinical Development Update Financial Results Clinical Development Radiopharmaceuticals Cost Management Regulatory Feedback
PRESS RELEASE published on 05/07/2026 at 08:00, 22 days 10 hours ago Pentixapharm Reports First Quarter 2026 Results and Highlights Clinical and Regulatory Momentum Pentixapharm Holding AG reports Q1 2026 financial results, highlights progress in clinical and regulatory activities, and provides full-year financial guidance Financial Results Regulatory Pentixapharm Q1 2026 Clinical
BRIEF published on 03/31/2026 at 08:05, 1 month 29 days ago Pentixapharm Holding AG Appoints Erik Merten to Executive Board Executive Board Radiopharmaceuticals Pentixapharm Erik Merten PANDA Program
BRIEF published on 03/31/2026 at 08:05, 1 month 29 days ago Pentixapharm Holding AG nomme Erik Merten au conseil d'administration Conseil D'administration Produits Radiopharmaceutiques Pentixapharm Erik Merten Programme PANDA
PRESS RELEASE published on 03/31/2026 at 08:00, 1 month 29 days ago Pentixapharm Holding AG Appoints Erik Merten to the Executive Board Pentixapharm Holding AG appoints Erik Merten as Chief Technology Officer (CTO) to enhance radiopharmaceutical development and manufacturing capabilities, supporting Phase 3 PANDA program and future commercialization Executive Board Radiopharmaceuticals Pentixapharm Holding AG Erik Merten Phase 3 PANDA Program
BRIEF published on 03/19/2026 at 10:19, 2 months 10 days ago Pentixapharm Holding AG to Reveal 2025 Financial Results Conference Call Clinical Trials Pentixapharm Radiotherapeutics 2025 Financial Results
Published on 05/29/2026 at 15:50, 2 hours 45 minutes ago Power Metallic Mines Announces Upsize of Brokered LIFE Offering for Gross Proceeds of up to C$30 Million
Published on 05/29/2026 at 14:30, 4 hours 5 minutes ago Sarama Completes Tranche 1 Equity Placement and ASX Cleansing Notice
Published on 05/29/2026 at 14:30, 4 hours 5 minutes ago Unusual Machines to Participate in June Investor Conferences
Published on 05/29/2026 at 14:20, 4 hours 15 minutes ago Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
Published on 05/29/2026 at 13:59, 4 hours 36 minutes ago AIP Realty Trust Announces First Quarter 2026 Results
Published on 05/29/2026 at 18:00, 35 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.26
Published on 05/29/2026 at 18:00, 35 minutes ago O3 Holding GmbH - Publication Q1 2026 Interim Report
Published on 05/29/2026 at 18:00, 35 minutes ago VAZIVA SA: MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
Published on 05/29/2026 at 18:00, 35 minutes ago Recticel Group versnelt groei in isolatiepanelen met geïntegreerde isothermische oplossingen na overname Isopanel NV
Published on 05/29/2026 at 18:00, 35 minutes ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 15:38, 2 hours 57 minutes ago Déclaration d'actions et de droits de vote au 30.04.2026
